Cargando…

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study

Detalles Bibliográficos
Autores principales: Jeong, Jong-Hyun, Bahk, Won-Myong, Kim, Do Hoon, Kim, Moon-Do, Kim, Won, Lee, Kwang Heun, Lee, Kyung-Uk, Woo, Young Sup, Yang, Jong-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616682/
http://dx.doi.org/10.1093/ijnp/pyw043.085
_version_ 1783266840273747968
author Jeong, Jong-Hyun
Bahk, Won-Myong
Kim, Do Hoon
Kim, Moon-Do
Kim, Won
Lee, Kwang Heun
Lee, Kyung-Uk
Woo, Young Sup
Yang, Jong-Chul
author_facet Jeong, Jong-Hyun
Bahk, Won-Myong
Kim, Do Hoon
Kim, Moon-Do
Kim, Won
Lee, Kwang Heun
Lee, Kyung-Uk
Woo, Young Sup
Yang, Jong-Chul
author_sort Jeong, Jong-Hyun
collection PubMed
description
format Online
Article
Text
id pubmed-5616682
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56166822017-11-27 PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study Jeong, Jong-Hyun Bahk, Won-Myong Kim, Do Hoon Kim, Moon-Do Kim, Won Lee, Kwang Heun Lee, Kyung-Uk Woo, Young Sup Yang, Jong-Chul Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616682/ http://dx.doi.org/10.1093/ijnp/pyw043.085 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Jeong, Jong-Hyun
Bahk, Won-Myong
Kim, Do Hoon
Kim, Moon-Do
Kim, Won
Lee, Kwang Heun
Lee, Kyung-Uk
Woo, Young Sup
Yang, Jong-Chul
PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
title PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
title_full PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
title_fullStr PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
title_full_unstemmed PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
title_short PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
title_sort ps85. efficacy and safety of generic escitalopram (lexacure) in patients with major depressive disorder: a 6-week, multi-center, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616682/
http://dx.doi.org/10.1093/ijnp/pyw043.085
work_keys_str_mv AT jeongjonghyun ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT bahkwonmyong ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT kimdohoon ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT kimmoondo ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT kimwon ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT leekwangheun ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT leekyunguk ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT wooyoungsup ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy
AT yangjongchul ps85efficacyandsafetyofgenericescitalopramlexacureinpatientswithmajordepressivedisordera6weekmulticenterrandomizedraterblindedescitalopramcomparativenoninferioritystudy